Building the Cure Foundation Inc
Nonprofit profile at a glance
- EIN
- 863126815
- IRS 990-EZ coverage
- 2021–2024
- Forms available
- Form 990-EZ 2024
- Location
- Parker, CO, USA
- Rating confidence
- Limited
- Sector
- Alliance/Advocacy Organizations
Reported finances
- Revenue
- $53,751
- Expenses
- $13,950
- Assets
- $54,808
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
7 people listed
Executive titles in this filing
- Desiree Freris (President and Founder)
People named in this filing
- Desiree Freris (President and Founder)
- Terry Kraiser (Treasurer)
- Angela Gonzales (Board Member)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Education related to congenital heart disease
What it reported doing in 2024
During 2024 BTCF executed a $45,000 Simple Agreement for Future Equity SAFE with Organamet Bio a research entity conducting studies related to congenital heart disease. The investment is intended as a program-related investment PRI to advance BTCFs charitable purpose of supporting research into novel treatments for HLHS. The amount is reported as an asset in Part II Line 24 and not as a grant expense in Part I. No returns have been realized to date. The program-related investment is made in accordance with 26 CFR Section 53.4944-3. The Board of Directors has formally ratified and approved the investment as a PRI. The primary purpose of this investment is to advance the Foundations charitable mission of supporting congenital heart disease research. Any potential return on investment is incidental to this charitable purpose.
Operating model
- Revenue model
- Donor-supported. 65% of the money available for current operations came from contributions and gifts.
- Distribution model
- Cannot be determined from the filing. The filing does not provide enough consistent spending detail to tell whether the nonprofit works directly or through others.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: NotEnoughData
- Transparency & Controls: 82
- Sustainability: 75
- Growth: 100
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: 74%; rating input score 96; 96th percentile among comparable filings
- Total-asset coverage ratio: 3.93; rating input score 80; 80th percentile among comparable filings
- Liabilities to assets ratio: Limited
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: 150% per year; rating input score 100; 99th percentile among comparable filings
- Revenue growth: 63.8% per year; rating input score 100; 98th percentile among comparable filings
- Asset growth: 97.1% per year; rating input score 100; 98th percentile among comparable filings
Details
- Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment
- Leadership: top reported pay $0 · 7 people listed
- Consistency: 6 of 6 current checks pass
- Schedules: 3 filed schedules
- Filing history: 4 filing years from 2021 to 2024
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- Review — Sustainability: Officer compensation ratio scored 56/100.